The potential of therapeutic cannabis is real. Since 1995, there have been over 25,000 peer-reviewed articles in various medical journals in the U.S. and around the world about the plant’s medicinal characteristics and potential for therapeutic use. Also during that time, over 30 states have approved medical cannabis programs...
U.S, July 9 2021 (ANALYTICALCANNABIS) It’s long been known that cannabis can impair a consumer’s memory and their ability to recall information.
But in a new study, a group of researchers have found that, contrary to their predictions, high potency cannabis concentrates don’t seem to significantly...
U.S, December 23, 2019 (MERRYJANE) Thirteen different legal weed vapes failed tests for lead contamination, which may explain why at least six Massachusetts residents have been sickened by state-regulated THC vapes. "Impermissible-levels-of-lead-found-in-massachusetts-legal-weed-vapes
Massachusetts cannabis regulators discovered dangerous levels of heavy metals in several...
AUSTRALIAN, January 21, 2020 (HEMPGAZETTE) There’s a lot of activity on the Australian cannabusiness scene, but what is happening at the patient end of things? Statistics from the Therapeutic Goods Administration (TGA) indicate significant growth in approvals, but it wouldn’t even be touching the sides of potential...
CANADA, October 2 2019 (ANALYTICALCANNABIS) Researchers at Western University, Canada, have uncovered the exact molecular mechanisms that cause CBD to block some of the negative psychiatric side effects associated with high levels of THC in cannabis.
Their study, the results of which were recently published in the Journal of Neuroscience, identified extracellular-signal regulated...
U.S, November 27, 2019 (HEMPGAZETTE) A recent study out of Washington State University indicates inhaled cannabis may reduce the intensity of headaches and migraines.
Led by Carrie Cuttler, a WSU assistant professor of psychology, a research term analyzed information submitted by more than 1,300 patients who used the Strainprint app...
U.S, January 29, 2020 (ANALYTICALCANNABIS) Several recent studies have suggested that CBD has an antipsychotic effect in people with existing forms of psychosis. But just how the cannabis compound is achieving this effect has remained unclear. Now, researchers from King’s College London say they may know the answer....
UNITED KINGDOM, October 9, 2019, (HEALTH EUROPA) - Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and cannabinoid science company based in the United States and, subject to approval from Zelda shareholders and all conditions of sale being met,...
U.S, November 27, 2019 (ANALYTICALCANNABIS) Cannabis may be a promising alternative for chronic pain sufferers who are turning to illicit opioids to manage their symptoms, according to the results of a new study.
Previous scientific studies have documented the behavior of chronic pain patients who are using cannabis as an alternative pain...
U.S, January 13, 2020 (GREENENTREPRENEUR) It really depends on your tolerance and what conditions you are treating, but here we remove some of the dosing mystery.
The brave new world of cannabidiol or CBD-infused products is growing. That means more product choices and...